Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac after Laser Microporation for Cutaneous Neurofibromas in NF1
NCT03090971Phase 2Completed
- Sponsor
- Fundação Educacional Serra dos Órgãos
- Start
- Feb 2017
- Primary completion
- Mar 2017
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diclofenac in neurofibromatosis type 1 (NF1), cutaneous neurofibroma (cNF), sponsored by Fundação Educacional Serra dos Órgãos. Started Feb 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
neurofibromatosis type 1 (NF1)cutaneous neurofibroma (cNF)
Beyond the preview
Go deeper on NCT03090971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090971.